EDIL3 and chronic pancreatitis: In the commercial TMA (TMA1, OD-CT-DgPan01-006), we found that EDIL3 was significantly up-regulated in chronic pancreatitis (CHP) tissues and PDAC tissues compared with normal pancreas (NP) (Figure 1F).